Healthpeak Properties inc (PEAK) |
|
|
|
EARNINGS REPORT by CSIMarket
Loss on Weak Sales
Healthpeak Properties Inc announced financial fourth quarter 2020 operating profit of $113.622 millions
![Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/realestate/Khozam_By_BandarSar_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg) For the financial fourth quarter 2020 Healthpeak Properties Inc losses widen of $ -0.04 per share compare to $0.09 a year ago and improved from $ -0.12 per share from the previous quarter. Sales declined in double digits by -18.81 % to $ 432 millions from $532 millions in the same quarter a year ago and sequentially Sales fell by -27.78 % from $598 millions. Net income of $150.245 millions in the financial fourth quarter 2020 increased by 217.25 % from net earnings of $47.359 millions reported in the financial fourth quarter 2020 a year ago. Healthpeak Properties Inc also emphasized it's improving profit margins, where net margin rose to 34.8% in financial fourth quarter 2020, and operating margin edged up to 26.32%. Looking into financial results for the fiscal year 2020, Healthpeak Properties Inc reported Sales of $ 1.64 billions and net income of $ 428 millions. Real Estate Operations Company explained also, that Eps surged by 755.56 % to $0.77 per share from $0.09 in the previous fiscal year, while Sales fell by -17.65 % from $2.00 billions a year ago. Healthpeak Properties Inc is expected to report next financial results on February 09, 2022.
|
Recently Reported Results |
Ansys Inc
Ansys Inc announced strong results in the fiscal fourth quarter of 2020, where Sales rose by 28.27% to $623.69 millions and eps advanced by 29.07 % to $2.46 per share, year on year.
Sequentially eps more than doubled by 182.86 % from $0.87 per share and Sales surged by 69.96 % from $366.97 millions. In the fiscal year 2020, Ansys Inc reported Sales of $1.68 billions and net income of $433.89 millions. Eps decreased by -5.33 % to $4.97 per share from $5.25 in the previous fiscal year, while Sales advanced by 10.91 % from $1.52 billions a year ago.
ANSS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Consumer Price Index
|
Vishay Intertechnology Inc
Company achieved eps growth of 168.98 % to $0.26 in the most recent fiscal period, Sales increased by 9.45% to $667.18 millions in comparison to $609.58 millions in the prior year quarter.
compared to previous quarter income per share increased by 12.45 % from $0.23 per share and Sales increased by 4.22 % from $640.16 millions. In the fiscal year 2020, Vishay Intertechnology Inc reported Sales of $2.50 billions and net income of $123.78 millions. Earnings deteriorated by -24.78 % to $0.85 per share from $1.13 in the previous fiscal year, while Sales decreased by -6.24 % from $2.67 billions a year ago.
VSH stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Ingredion Incorporated
In the fourth quarter of 2020 Ingredion Incorporated income increased by 5.5 % of $1.71 per share compared to $1.62 a year ago and earnings grew by 25.46 % from $1.36 per share from the previous quarter.
Sales declined in double digits by -16.07% to $1.59 billions from $1.90 billions in the same quarter a year ago and sequentially Sales increased by 6.06 % from $1.50 billions. In the fiscal year 2020, Ingredion Incorporated reported Sales of $5.99 billions and net income of $354.00 millions. Profits per share fell by -15.99 % to $5.15 per share from $6.13 in the previous fiscal year, while Sales decreased by -3.58 % from $6.21 billions a year ago.
INGR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Perdoceo Education Corp
Company reports $-69.05 million loss, as impairment charges strip off $0.61 million from the most recent fiscal period results.
Earnings grew from the preceding quarter from $0.56 per share, from $169.13 millions. In the fiscal year 2020, Perdoceo Education Corp reported Sales of $687.31 millions and net income of $124.26 millions. Eps soared by 79.38 % to $1.74 per share from $0.97 in the previous fiscal year, while Sales advanced by 9.5 % from $627.70 millions a year ago.
PRDO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Employment Report
|
Producer Price Index
|
Housing Starts
|
Fresh Del Monte Produce Inc
Company has managed to turn into profitability on declining sales, eps was at $0.02 in the most recent fiscal period but Sales declined by -2.23% to $1.00 billions compared to previous year quarter.
From the preceding quarter, eps dropped from $0.37 per share and Sales increased by 1.27 % from $989.70 millions. In the fiscal year 2020, Fresh Del Monte Produce Inc reported Sales of $4.20 billions and net income of $46.30 millions. Earnings deteriorated by -24.82 % to $1.03 per share from $1.37 in the previous fiscal year, while Sales decreased by -6.39 % from $4.49 billions a year ago.
FDP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Graham Holdings Co
Graham Holdings Co posted very strong earnings results in the financial period ending Dec 31 2020, where income surged by 73.03 % at $47.75 per share, Sales grew modestly by 3.08% to $787.01 millions from the same quarter a year ago.
In the previous quarter company realized Sales of $716.98 millions and bottom line of $15.22 per share. In the fiscal year 2020, Graham Holdings Co reported Sales of $2.89 billions and net income of $299.97 millions. Eps decreased by -5.03 % to $58.13 per share from $61.21 in the previous fiscal year, while Sales decreased by -1.47 % from $2.93 billions a year ago.
GHC stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Avista Corporation
Avista Corporation had fourth quarter of 2020 Sales increase of 4.35% to $380.42 millions from $364.56 millions from the same quarter a year ago, company grew eps by 11.84 % to $0.85, from $0.76 in the prior year quarter.
In the previous quarter company realized Sales of $272.65 millions and bottom line of $0.07 per share. In the fiscal year 2020, Avista Corporation reported Sales of $1.32 billions and net income of $129.49 millions. Earnings deteriorated by -36.03 % to $1.90 per share from $2.97 in the previous fiscal year, while Sales decreased by -1.76 % from $1.35 billions a year ago.
AVA stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Costar Group Inc
Company's earnings deteriorated despite Sales growth in the financial time frame ending Dec 31 2020, eps dived by -62.11% to $0.91 per share, while Sales increased in double digits by 18.59% to $444.39 millions, from the same quarter a year ago.
Earnings deteriorated from the preceding quarter by -38.61% from $1.48 per share, Sales increased by 4.41 % from $425.62 millions. In the fiscal year 2020, Costar Group Inc reported Sales of $1.66 billions and net income of $227.13 millions. Earnings deteriorated by -31.05 % to $5.93 per share from $8.60 in the previous fiscal year, while Sales improved by 18.53 % from $1.40 billions a year ago.
CSGP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Icon Plc
Icon Plc announced disappointing results, eps deteriorated by -9.43% to $6.15 from $6.79 and Sales declined by -0.3% to $2.80 billions in the fourth quarter of 2020, year on year.
From the preceding quarter, from $0.00 per share and from $0.00 millions. In the fiscal year 2020, Icon Plc reported Sales of $2.80 billions and net income of $332.96 millions. Eps decreased by -9.43 % to $6.15 per share from $6.79 in the previous fiscal year, while Sales decreased by -0.3 % from $2.81 billions a year ago.
ICLR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Sunesis Pharmaceuticals Inc
In the most recent fiscal period Sunesis Pharmaceuticals Inc decreased loss of $-0.04 per share compared to $-0.05 a year ago and improved from $-0.29 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $2.07 millions in the same quarter a year ago and sequentially from $0.00 millions. Sunesis Pharmaceuticals Inc reported net loss of $-21.61 millions and Sales of $0.12 millions for the fiscal year 2020. Net loss per share has widen to $-1.53 from $-0.27 in previous fiscal year, while Sales decreased by -94.21 % from $2.07 millions a year ago.
SNSS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|